Technology and Methodology
JCSG has developed and integrated new technologies covering the gene-to-structure process to enable high-throughput structural biology at scale.
Explore the pipeline →
PSI Production Center
The Joint Center for Structural Genomics applies high-throughput methods to determine three-dimensional protein structures and expand coverage of the protein structure universe.
Technology, structures, and annotations supporting the global structural biology community.
JCSG has developed and integrated new technologies covering the gene-to-structure process to enable high-throughput structural biology at scale.
Explore the pipeline →JCSG has determined high-resolution structures of more than 1,000 proteins — many are first structural representatives of uncharacterized protein families.
Browse structures →Through TOPSAN, a Wiki-based information and annotation portal, the community collaboratively annotates protein structures solved by structural genomics centers.
About TOPSAN →JCSG is led by an interdisciplinary team of investigators across its consortium institutions.
Ian A. Wilson
Director & Principal Investigator
Scott A. Lesley
Co-Principal Investigator
Genomics Institute of the Novartis Research Foundation (GNF)
Adam Godzik
Co-Principal Investigator
Ashley M. Deacon
Co-Principal Investigator
Marc-André Elsliger
Co-Investigator
Explore how structural genomics underwrites modern peptide therapeutics and protein science.
How high-throughput structural genomics pipelines accelerate the design, optimisation, and validation of peptide-based therapeutics.
Read more →A clear, structure-first explanation of how proteins and peptides recognise one another, and why those interactions matter.
Read more →Protein–peptide interactions orchestrate signalling, trafficking, and gene regulation across the cell.
Read more →Why structural genomics is the quiet engine behind modern peptide therapeutics — from target validation to clinical candidate selection.
Read more →How structural genomics consortia characterise protein–peptide interactions and feed the data back into therapeutic design.
Read more →Tracing the workflow that converts a deposited protein structure into a marketed peptide drug.
Read more →Explore the consortium's mission, meet the investigators, and get in touch with the JCSG team.